Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Takeda Pharmaceutical Company Limited

Market Cap 7,958B 49.31B 43.03B 39.64B 37.36B 69.69B 4,652B 70.3B 469B 183B 2,292B 185B 181B P/E 2026
46.4x
P/E 2027 * 41x
Enterprise Value 11,897B 73.73B 64.34B 59.27B 55.86B 104B 6,955B 105B 701B 273B 3,426B 277B 271B EV / Sales 2026
1.14x
EV / Sales 2027 * 2.56x
Free-Float
99.25%
Yield 2026
3.53%
Yield 2027 * 4.06%
1 day+2.00%
1 week-0.65%
Current month-1.58%
1 month-4.55%
3 months-13.45%
6 months+12.18%
Current year+4.18%
1 week 4,938
Extreme 4938
5,158
1 month 4,710
Extreme 4710
5,362
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 59 2015-03-31
Director of Finance/CFO 48 2024-03-31
Chief Tech/Sci/R&D Officer 47 2022-01-31
Director TitleAgeSince
Director/Board Member 59 2014-05-31
Director/Board Member 60 2015-05-31
Director/Board Member 74 2016-05-31
Date Insider Type Main position Quantity % Market Cap.
04-26Free

Chief Technology Officer

212,470 0.0134%
04-26Free

Chief Financial Officer

15,614 0.0010%
04-26Free

Chief Executive Officer

323,248 0.0203%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%-0.65%+15.93%+10.17% 48.69B
-1.21%-3.33%+38.84%+145.38% 992B
-2.48%-4.23%+49.88%+39.07% 564B
-2.14%-3.76%+16.72%+56.15% 391B
-1.18%+0.68%+24.66%+16.53% 330B
-2.36%-2.30%+23.37%+11.59% 280B
-2.45%-0.84%+23.51%+30.06% 279B
-1.91%-1.06%-42.60%-49.25% 196B
-1.19%-0.04%+16.39%+47.00% 184B
-1.35%+1.88%+14.59%+56.94% 156B
Average -0.55%+0.11%+18.13%+36.36% 341.99B
Weighted average by Cap. -0.47%-0.52%+26.94%+62.45%

Financials

2026 2027 *
Net sales 4,531B 28.08B 24.51B 22.58B 21.27B 39.68B 2,649B 40.03B 267B 104B 1,305B 105B 103B 4,630B 28.69B 25.04B 23.07B 21.74B 40.55B 2,707B 40.9B 273B 106B 1,334B 108B 105B
Net income 174B 1.08B 944M 869M 819M 1.53B 102B 1.54B 10.28B 4.01B 50.25B 4.06B 3.97B 184B 1.14B 995M 916M 863M 1.61B 108B 1.62B 10.84B 4.23B 52.96B 4.28B 4.19B
Net Debt 3,940B 24.41B 21.31B 19.63B 18.5B 34.5B 2,303B 34.8B 232B 90.53B 1,135B 91.69B 89.73B 3,914B 24.26B 21.17B 19.5B 18.38B 34.28B 2,288B 34.58B 231B 89.95B 1,127B 91.11B 89.16B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,455
Date Price Change Volume
26-06-18 5,037.00 ¥ +2.00% 3,465,300
26-06-17 4,938.00 ¥ -1.63% 3,890,400
26-06-16 5,020.00 ¥ -1.34% 3,072,600
26-06-15 5,088.00 ¥ +0.12% 3,450,400
26-06-12 5,082.00 ¥ +0.97% 4,711,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,037.00JPY
Average target price
6,086.87JPY
Spread / Average Target
+20.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!